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A B S T R A C T
Background: Leptin is produced by fat cells and is secreted into the blood stream. Lep-
tin is freely ﬁltered into the renal tubules but its concentration in the urine is very low. 
Serum leptin level is higher in continuous ambulatory peritoneal dialysis (CAPD) pa-
tients, compared to the healthy individuals. Serum leptin level may have correlation 
with inﬂammatory markers and peritonitis. 
Objectives: The aim of this study was to evaluate relationship of serum leptin level with 
peritonitis, the major complication of CAPD, in these patients.
Patients and Methods: In a cross sectional study, 75 CAPD patients in Al-Zahra Hospital 
in Isfahan were enrolled from October 2007 to February 2008. Serum levels of leptin, 
Kt/V, demographic ﬁndings, total numbers of peritonitis and presence of peritonitis 
in last year, were recorded in all patients, based on history, physical exam and patients’ 
ﬁles.
Results: Mean age of the patients was 53 ± 15 years. Mean serum leptin level in females 
and males were 27 ± 23μg/L and 16 ± 13μg/L respectively. At univariate general linear 
model (GLM), there was a signiﬁcant correlation between serum leptin level with 
body mass index (BMI) (P < 0.001, ɵ = 2.7) and duration of renal failure (P = 0.01). No 
correlation was seen between serum leptin level and total number of peritonitis in the 
past. However, there was negative relationship between serum leptin level and pres-
ence of peritonitis in the last year (P = 0.004, ɵ = 6).
Conclusions: Presumably, we could not use serum leptin level as a marker of infection 
in long term; however, serum leptin level may be used as an index of peritonitis and 
morbidity in short time.
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 Implication for health policy/practice/research/medical education: 
Serum leptin levels could not be used as a marker of infection in long-term but it may be applied as an index of peritonitis and 
morbidity in short-time.
1. Background
Leptin is a 16000 Dalton protein that is produced by fat 
cells, it is secreted into the blood stream, and it attaches 
to the leptin binding protein, and reaches hypothalamus 
via CSF. It decreases neuropeptide Y (NPY), suppresses 
appetite, and with blockade of (melanocyte stimulating 
hormone) MSH, reduces hunger which in turn decreases 
weight (1). Kidneys play an important role in metabolism 
and excretion of leptin. It is freely ﬁltered into glomeruli 
with very little excretion in urine (2), because it is 
probably reabsorbed and metabolised in tubules (3). 
Serum leptin level is higher in chronic renal failure, 
hemodialysis and CAPD patients compared to general 
population (4, 5). Some studies reported that the level of 
leptin in CAPD patients and women is higher compared 
to hemodialysis patients and men, respectively (6, 7). 
Exact cause of elevated serum leptin level in renal failure 
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patients is not clear; however, some factors including 
decreased functional mass of kidneys, hemodialysis 
membrane and type of dialysis (hemodialysis versus 
peritoneal dialysis) (8, 9), low serum erythropoietin level 
(10), chronic inﬂammation and hyperinsulinemia (11) 
may also have a role. Some studies show that serum leptin 
level is related to inﬂammatory factors such as C-reactive 
protein (12, 13). Leptin may act as an inﬂammatory index 
or cachexia induced factor in CAPD patients (14, 15). Lam 
et al. showed that during the acute phase of peritonitis, 
serum leptin level increases and then returns to baseline 
during 42 days (16). 
2.Objectives
There are few comprehensive studies on relation 
between serum leptin level and peritonitis or 
inﬂammatory factors which remains precisely unclear 
and this study was carried to investigate it further. There 
fore, this study was conelucted to ﬁnd this relation.
3. Patients and Methods 
In a cross-sectional study in Al-Zahra Hospital of Isfahan 
from 101 CAPD patients, 75 patients fulﬁlled inclusion 
criteria and were entered in the study. Method of 
sampling was convenient sampling. Patients were asked 
by Questionnaire and assessed by physical examination, 
patient ﬁle and laboratory examination. Information 
in the questionnaire was collected by PD nurse and 
from patient ﬁle from October 2007 to February of 
2008. Inclusion criterion was: being at least 3 months 
on peritoneal dialysis, and exclusion criteria were non-
compliance of patients, inadequate blood sampling 
and peritonitis during study. Exchange of dialysis ﬂuid 
in patients was 4 to 5 times per 24 hours. Diagnosis of 
peritonitis was based on the presence of 2 of following 
criteria: 1) clinical ﬁndings such as abdominal pain, fever, 
turbid PD eﬄuent, 2) presence of WBC equal or greater 
than 100/mL in eﬄuent and 3) positive PD eﬄuent 
culture. 
Fasting blood samples were taken in the peritoneal 
dialysis (PD) clinic for measurement of leptin (DRG 
kit, radioimmunoassay (RIA), Germany), blood urea, 
creatinine and serum albumin (Bromo Cresol Green 
(BCG) method); furthermore, creatinine and urea 
concentrations were measured in dialysate and urine 
samples. Body mass index (BMI) calculated by the formula 
[body weight (kg) / height ² (m)] and total number of 
peritonitis, presence of peritonitis in the last year and 
demographic information of patients was obtained by 
their ﬁles. All data collected by PD nurse and data related 
to calculating Kt/V analyzed by PD Adequest 2 software, 
Baxter, USA. All laboratory tests were carried out 10 hours 
of fasting and in a single laboratory. Patients were asked 
by Questionnaire, assessed by physical examination, 
patient ﬁle and laboratory examination. Separated 
plasma of patients were kept in -20ºC environment. After 
collection of all samples, measurements of variables were 
done simultaneously. T-test and univariate general linear 
models (GLM) were used for the analysis of the variables 
statistically. A p value less than 0.05 were considered as 
signiﬁcant. All data and information are conﬁdential 
and an informed consent was taken from every patient 
for obtaining samples and other processes of this study.
4. Results
Average age of the patients was 53 ± 15 years. History of 
hemodialysis was seen in 23 patients. The most common 
cause of end-stage renal disease was diabetes mellitus 
(48%) (Table 1). The mean age of DM patients was higher 
than patients without DM (60 vs. 46 years in non-DM 
cases) (P = 0.03). Mean serum leptin level in women and 
men were 27 ± 23 μg/l and 16 ± 13 μg/l (P = 0.001, r = - 0.4), 
respectively. At univariate GLM, has been shown in Figure 1,
no correlation was seen between serum leptin level and 
total number of peritonitis in past but there was negative 
relationship between serum leptin level and frequency 
of peritonitis in the last year (P = 0.004, ɵ = 6). There 
was a signiﬁcant correlation between serum leptin level 
with BMI (P < 0.001, ɵ = 2.7) and a negative relationship 
was observed between age and serum leptin level (P = 
0.028, ɵ = - 0.32). The patients with longer duration of 
chronic kidney disease had higher serum leptin level (P 
= 0.01, ɵ = 0.09); however, no relation was seen between 
serum leptin concentration and duration of CAPD (Table 
2). There was no signiﬁcant correlation between serum 
leptin level and Kt/V, history of hypertension, and number 
of peritoneal dialysis exchange per day (P > 0.05). 
5. Discussion
Serum leptin level in CAPD patients is higher than that 
of normal population and HD patients. Higher level 
Cause Patient, No. (%)
ADPKD a 1 (1.3)
DM a + HTN 4 (5.3)
DM without HTN 32 (42.7)
DM ± HTN 36 (48)
Glomerulonephritis 1 (1.3)
Gout 1 (1.3)
Hypertension 17 (22.7)
Pregnancy 2 (2.7)
Renal stone 4 (5.3)
SLE a 2 (2.7)
Unknown 11 (14.6)
Total 75 (100)
Table 1. Distribution of Causes of End-stage Renal Disease in Peritoneal Di-
alysis Patients
a Abbreviations: ADPKD, Autosomal dominant polycystic kidney disease; DM, 
Diabetes mellitus; SLE, Systemic Lupus Erythematosus
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of serum leptin in CAPD patients may be due to higher 
fat mass and serum insulin level in these patients (17). 
Several studies have shown that serum leptin level is 
higher in females with chronic kidney disease compared 
to males (6, 18, 19). In CAPD patients, the highest serum 
leptin level has been observed around 8 AM and it might 
be due to nocturnal glucose overload in (20). In these 
patients, serum leptin level does not correlate with Kt/V 
and protein consumption (13, 17). Similarly, we did not 
ﬁnd relation between leptin and Kt/V and also between 
leptin and number of exchange during 24 hours. It 
means that serum leptin may be not a good index for 
dialysis adequacy. In the current study, serum leptin 
level was higher in women compared to men and serum 
leptin level had a linear correlation with BMI. Our result 
is similar to the ﬁndings of Parry (17) and Kagen (18); in 
contrast, it is not consistency in the data of Kim (19). 
The reason for these diﬀerences could be partly due to 
discrepancy in the number of the patients studied. 
Mak et al. (12) reported a correlation between serum 
leptin level and serum CRP in rats. In addition, Lee et al. 
(20) found that serum leptin had relation with CRP and 
IL-6 in hemodialysis patients (21). Chen et al. (22) showed 
that leptin had no correlation with inﬂammatory factors 
(CRP-IL-6-TNFα) in CAPD patients. Yilmas et al. (13) and 
Landt et al. (23) also reported that there is no relation 
between leptin and CRP. Prez fontan et al. (24) showed 
that serum leptin level has correlation with mortaliy in 
CAPD patients. Based on above mentioned studies we 
can conclude that leptin may have a role in cachexia 
and malnutrition seen in CAPD patients. Lam et al. (16) 
reported that in the CAPD patients, leptin level increases 
in acute phase of peritonitis and then it decreases slowly 
to the baseline level after 42 days. Also Bracho-Riquelme 
et al. demonstrated the serum leptin level less than 10 
ng/mL is a negative prognostic factor in patients with 
moderate to severe peritonitis of CAPD patients (25). Our 
study showed that serum leptin level have no relation 
with total number of previously reported peritonitis but 
leptin level is lesser in patients with peritonitis during last 
year. Our ﬁndings have some similarity with the ﬁndings 
of Lam (16); therefore, we can conclude that serum 
leptin level increases in acute peritonitis and gradually 
declines to the baseline and even lower than baseline 
level. Limitations of our study were small number of 
cases and lacking of follow up. We recommend greater 
prospective studies with longer duration of follow up 
and checking other inﬂammatory markers such as ESR, 
C-reactive protein, serum ferritin and cytokines. We 
conclude that serum leptin level cannot be used as a good 
index for total previous number of peritonitis. However, 
more studies are needed to be carried out to reveal the 
relationship between leptin and peritonitis.
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Variables Minimum Maximum Mean ± SD
Leptin, μg/L 0.09 101.00 22.00 ± 23.00
WEIGH, kg 36.00 95.00 66.83 ± 13.49
BMI a, kg/m2 14.20 33.30 24.26 ± 3.89
Kt/V 1.08 4.80 2.42 ±0.80
Frequency of peritonitis at all 0.00 8.00 0.91 ± 1.38
Frequency of peritonitis during last year 0.00 7.00 0.4533 ± 1.00
Duration of renal failure, mo 0.50 300.00 43.47 ± 56.03
Duration of peritoneal dialysis, mo 3.00 70.00 20.16 ± 13.79
Duration of hemodialysis, mo 0.00 72.00 4.27 ± 12.61
Number of PD a exchanges per day 2.00 5.00 3.8 ± 0.78
Table 2. Clinical and Biochemical Parameters of Patient During the Study
a Abbreviations: BMI ,body mass index; PD, peritoneal dialysis
Figure 1. Relationship of Serum Leptin Level with Number of Peritonitis in Last 
Year
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